Visual acuity after vitrectomy for rhegmatogenous retinal detachment depends on the type of foveal microstructural changes. The purpose of the research — the study of the relationship between visual acuity and foveolar microstructure investigated by means of optical coherence tomography in patients after the treatment of rhegmatogenous retinal detachment. There were investigated 32 patients, the time of observation was 12 months. The defects of the junction between internal and outer segments were registered in 17 eyes (53.1 %), external limited membrane defects were found in 5 eyes (15.6 %). There was a negative correlation between the presence of those defects and the maximum correctable visual acuity (r= –0.39, p <0.05; r = –0.65, p <0.05 respectavely). Remains of epiretinal membrane without traction component were identified in 17 cases (53.1 %), macular edema — in 4 eyes (12.5 %), there was no correlation between those findings and maximum correctable visual acuity. There was a negative correlation between the remoteness of rhegmatogenous retinal detachment and the maximum correctable visual acuity (r = –0.49, p <0.05). It was concluded that the main changes affecting the maximum correctable visual acuity were located in the outer parts of the fovealar area.
VIEWS 3739
This article discusses the principles of prevention and treatment of deep vein thrombosis of the lower extremities during total hip replacement (THR). Prevention of venous thromboembolism after THR should be carried out with modern drugs. Patients with hip fracture should be carried out prevention from the moment of the injury before surgery using unfractionated heparin or low molecular weight heparins. The duration of prevention after surgery should be at least 28–35 days. The combination of pharmacological and mechanical methods of prophylaxis to the most extent reduces the risk of deep vein thrombosis after THR. No need to be monitored, oral and direct mechanism of action not associated with the concentration of antithrombin III give the advantage to the new oral anticoagulants (dabigatran, rivaroxaban, apixaban) in comparison with injected low-molecular-weight heparins and unfractionated heparin. Rivaroxaban and dabigatran may be used for the treatment of deep vein thrombosis, which is also an advantage of these drugs. Performing ultrasonic angioscanning during the first 5 days after the surgery, is most likely justified for patients with decreased locomotor activity, venous thromboembolic complications or a history of abuse prevention protocol. Deep vein thrombosis after THR is secondary, so long-term treatment for several months seems unjustified.
VIEWS 3888